Help shape GoConqr. What should we add next?

Flashcards

Diabetes mellitus

sophietevans English 122 cards

Cards in this deck (122)

  1. 1Give a brief description of diabetes mellitus.An incurable condition defined by the consistency of the urine, i.e. sticky and sweet with glucose, and characterised by a feeling of thirst and fatigue, with frequent urination.
  2. 2At what age is the onset of type 1/insulin-dependent diabetes?In childhood/adolescence.
  3. 3Is the condition still considered to be type 1 diabetes when insulin dependent diabetes develops/presents >30 years old?No, this is considered to be type 3 diabetes.
  4. 4What propensity to develop type 1/insulin dependent diabetes is genetic?~40% genetically predisposed, as roughly this proportion of monozygotic twins develop type 1 diabetes so an environmental factor is likely to contribute, when superimposed on an existing heritable predisposition.
  5. 5It is unknown EXACTLY how the genetic predisposition to works, but how is it thought to lead to the development of diabetes?It is thought that there is a mutation in the human leukocyte antigen (HLA) region of DNA. The 'self' antigen of β cells in the pancreas is not properly developed so they are targeted by sensitised cytotoxic T lymphocytes which deplete them.
  6. 6What is 'insulitis'?An infiltrate of lymphocytes, neutrophils and macrophages that builds up in and around the islets of Langerhans due to the destruction of β cells.
  7. 7What percentage of type 1/insulin dependent diabetics also manifest other organ-specific autoimmune diseases, and what are some examples of these diseases?10% of type 1 diabetics. These organ-specific autoimmune diseases may be chronic thyroiditis, Graves disease, myasthenia gravis, Addison disease, and pernicious anaemia.
  8. 8Which group of people do environmental triggers produce a stronger effect (with regard to diabetes)?Those with a genetic predisposition to diabetes.
  9. 9Describe some environmental triggers for type 1/insulin dependent diabetes.Viruses or chemicals that deplete the β cells and result in diabetes, or which have similar antigens to pancreatic cells resulting in β cells also being targeted.
  10. 10Describe the pathology of type 1/insulin dependent diabetes.Accumulation of lymphocyte/macrophage/neutrophil infiltrate around and in the islets; with chronic type 1 diabetes the β cells can be depleted until they are no longer discernible; loss of β cells results in variably sizes islets (many of which appear as ribbon like cords which are difficult to distinguish from surrounding acinar tissue); interlobular and intra-acinar fibrosis of exocrine pancreas; and atrophy of acinar cells.
  11. 11Describe the clinical features of type 1/insulin dependent diabetes.Type 1 diabetes usually develops in childhood or early adolescence, but does develop in later decades. Metabolic acidosis, weight loss, dehydration and ion imbalance are common presentations. Patients are thin and drawn in appearance due to muscle and fat wastage. Type 1 diabetes often coincides with another conditions such as an infection, so there may be symptoms of that too such as a fever. Vague symptoms often experienced weeks/months before diagnosis include: polyuria (increased urine output), polydipsia (increased thirst due to diuresis caused by glucosuria), and polyphagia (insatiable appetite due to inefficient energy utilisation).
  12. 12What is the basic mechanism of type 1/insulin dependent diabetes?The β cells of the islets of Langerhans in the pancreas are destroyed, by viruses/chemicals and genetic predisposition in varying proportions, so that they can no longer produce insulin. This results in significantly decreased glucose uptake to the individual's cells, and severely decreased energy utilisation.
  13. 13What is the main difference between type 1 and type 2 diabetes?In type 1 diabetes, the β cells are destroyed so that little to no insulin is produced. In type 2 diabetes, insulin is produced but insulin receptors on cells are 'insensitive' to it, and so insulin cannot aid transport of glucose into the cells.
  14. 14Multifactorial genetic inheritance is a key factor in the development of type 2 diabetes. What proportion of development is due to genetic predisposition, and why is this not a certain figure?~90% of type 2 diabetes development is thought to be due to genetic predisposition, as when one monozygotic twin develops it, the other almost invariably does too. However, the exact mechanism is unknown, particularly as ~80% of type 2 diabetics are obese so the predisposition could be to obesity (e.g. in Hawaiians).
  15. 15List some causes of insulin resistance.Obesity/inactivity, medications, type 2 diabetes, hypertension, genetics, dyslipidaemia, atherosclerosis, rare disorders, ageing, etc.
  16. 16In many type 2 diabetics, what two cellular processes are impaired?The secretion of insulin by β cells is impaired, as well as the uptake of insulin by cells of the periphery (adipose/muscle) being reduced.
  17. 17What deficiency can prevent insulin from being released from β cells?Reduced gene expression can result in a deficiency or complete lack of the glucose transporter (GLUT-2) that glucose binds to in order to be released from the β cell. The event resulting in the reduced gene expression is not known.
  18. 18List some possible causes of reduced insulin reception/glucose uptake by cells.Mutations in the gene for glucokinase which phosphorylates glucose on entry into the β cells can reduce the β cell's metabolism and ability to secrete insulin; a reduced number of insulin receptors in skeletal muscle/adipose cell plasma membranes, resulting in a high concentration of circulating insulin and reduced glucose entry to cells (and thus hyperglycaemia) (these are reduced in obese people); a mutation in the β subunit of the insulin receptor so that is has a different shape and insulin cannot bind (rare); point mutations in tyrosine kinase resulting in defective catalytic activity of the receptor (rare); and mutant insulin molecules being unable to bind to receptors.
  19. 19Obesity can contribute towards developing type 2 diabetes but it does not directly cause it. Which group of people are more likely to develop type 2 diabetes?Those with a genetic predisposition to obesity.
  20. 20People who store their fat in certain places can get rid of it more easily through rigorous food consumption control. People who store fat in which areas can get rid of it more easily? And which areas are more difficult to get rid of fat through rigorous food control?Those who store fat in their upper trunk/shoulders/arms can reduce this fat volume more easily by rigorous food consumption control than those who store fat in their pelvic girdle.
  21. 21People who store fat in which areas are more likely to develop type 2 diabetes?Those who store fat in their arms/shoulders/upper trunks.
  22. 22Energy metabolism varies greatly between populations and individuals. Explain what this means for obesity and type 2 diabetes.A person may not over-eat or comfort eat but may still develop obesity, and further a person may not be obese but may still develop type 2 diabetes. There is variance.
  23. 23Describe the pathology seen in type 2 diabetes.Pathology in type 2 diabetics is greatly variable and not easily diagnostic. In some islets, fibrous tissue accumulates and may even obliterate islets. In some patients amyloid (amylin polypeptide, secreted alongside insulin) accumulates; this is particularly the case in >60 year old type 2 diabetics, but is also present in ~20% of nondiabetics of the same age so it can also be contributed to age.
  24. 24Is diabetes life threatening?Type 1/insulin dependent diabetes is life threatening, whereas type 2/insulin independent diabetes is not life threatening in the beginning of the disease but if left untreated for long periods can become life threatening.
  25. 25At what age is the onset of type 2 diabetes?It is generally developed/seen in >30 year olds, however juvenile cases are now being seen.
  26. 26Without insulin, what are the metabolic consequences for an individual?Without insulin, glucose cannot reach cells for respiration. Cells signal that they have no glucose, but the liver also cannot metabolise the glucose for the cells so it initiates its fasted-state pathways : glycogenolysis and gluconeogenesis. The hyperglycaemia cannot be resolved because of the lack of insulin, but the cells are still not receiving any insulin so this energy deficit activates the liver to produce further glucose from amino acids and glycerol.
  27. 27What type of oxidation do fatty acids undergo in the liver?β oxidation.
  28. 28Fatty acids enter the blood for transport to the liver from peripheral adipose tissue. What happens to them in the liver?They undergo β oxidation to form glucose and other respiratory substrates, but the liver is limited in its ability to send fats through the Krebs cycle and excess fatty acids are converted to ketones.
  29. 29Ketone bodies can re-enter the circulation and can be used by other tissues, e.g. muscle and brain, for ATP synthesis. However, what can happen from here?Ketones are also metabolic acids, creating a state of ketoacidosis. This can also be a result of anaerobic metabolism due to limited citric acid cycle reactants, but the primary source is ketone bodies produced by fatty acid metabolism.
  30. 30What is metabolic acidosis (in tissues)?When the body produces too much acid. If untreated, it can lead to acidaemia, in which the pH of the blood sinks below <7.35.
  31. 31List some possible symptoms of ketone acidosis.Increased ventilation (as rapid deep breaths increase the rate of CO2 exhalation and lower serum CO2 levels to concentrate for the acidosis - less HCO3); anxiety due to hypoxia; acidification of the urine; nausea; vomiting; abdominal pain; altered appetite; weight loss (long term); muscle weakness; bone pains; and hyperkalaemia (above normal levels of K+ ions in the circulating blood as insulin is not available to facilitate its transport into cells to such an extent that excretion in the urine does not compensate).
  32. 32What is anaerobic metabolism, which creates lactate, caused by?Low blood pressure which decreases blood flow and therefore O2 delivery to the peripheral tissues (skeletal muscle/adipose).
  33. 33What can happen if lactate leaves the cells and enters the blood?It may contribute to acidosis and potentially acidaemia.
  34. 34If untreated, what can ketoacidosis and hypoxia from circulatory collapse lead to? What is the treatment?It can lead to coma and even death. Treatment is insulin replacement as well as fluid and ion replacement.
  35. 35What is the equation for glycolysis (words)?Glucose + NAD + CoA --> Acetyl CoA + NADH + CO2
  36. 36What is lipolysis?The breakdown of adipose tissue into fatty acids and glycerol.
  37. 37Glycolysis and the Krebs cycle usually generate energy in the form of ATP through oxidative phosphorylation of acetyl CoA. What does lipolysis do?Lipolysis provides substrates for β oxidation (fatty acids) and gluconeogenesis (glycerol) in the absence of glucose.
  38. 38Although hepatic glucose is still increased as gluconeogenesis is occurring in the liver, the glucose STILL cannot cross the cell membranes in the body. What happens to the fatty acids in β oxidation?The fatty acid is oxidised to produce many acetyl CoA molecules which go through the Krebs cycle to produce CO2 and ATP, as well as undergoing enzyme-mediated reactions to form CO2 and acetone (a ketone).
  39. 39What concentration can CO2/acetone reach in untreated diabetes?10-20mM. The pH of the blood drops due to this production.
  40. 40Fatty acid metabolism produces acetyl CoA faster than the Krebs cycle can use it as a substrate. What happens to this extra acyl?It is converted to ketone bodies.
  41. 41What does the body metabolise after the peripheral adipose tissue?Skeletal muscle is broken down to its amino acids to provide a substrate for ATP synthesis. These undergo gluconeogenesis.
  42. 42What can alanine be used to form in gluconeogenesis in the perceived absence of glucose in diabetes?Pyruvate for the Krebs cycle.
  43. 43What physical effects does utilisation of peripheral skeletal muscle tissue have?It leads to muscle wastage and contributes, along with loss of adipose tissue and the pallor of low energy, to the thin, drawn appearance of type 1 diabetics.
  44. 44Can the glucose produced by skeletal muscle breakdown and gluconeogenesis be used by cells for respiration in untreated diabetes?No, because it still can't get into the cells due to the lack of insulin, no matter how severe the hyperglycaemia! The energy deficit deepens and the breakdown of compensatory tissues continues.
  45. 45The presence of what in the circulation of diabetics will make the blood more viscous?Glucose and triglycerides.
  46. 46Why are glycosylated low density lipoproteins (LDLs) made available to blood vessel walls but non-glycosylated LDLs aren't?Because glycosylated LDLs do not readily bind to the LDL receptors in the liver and so are not removed from the circulation.
  47. 47What might be the result of LDL deposition in the blood vessels of diabetics?Platelet aggregation and thrombosis.
  48. 48What risk factor for atherosclerosis and cardiovascular disease is common in adult diabetics?Hypertension.
  49. 49What is the major cause of death in diabetics?Atherosclerotic coronary artery disease.
  50. 50How is dehydration caused in uncontrolled diabetes?The presence of ketone bodies, glucose and glycosylated proteins increases osmolarity and draws blood from the cells into the circulation.
  51. 51Dehydration and acidosis can lead to what?A change in brain function that can lead to unconsciousness and coma.
  52. 52What are the three types of diabetic coma?Severe diabetic hypoglycaemia, diabetic ketoacidosis, and hyperosmolar non-ketotic coma.
  53. 53List three things that can lead to hypoglycaemia in a diabetic.Low food intake, increased exercise, and over-injection of insulin.
  54. 54Why might a diabetic patient going into a severe hypoglycaemic coma sweat excessively and have a rapid heart rate?Because hypoglycaemia initiates an adrenalin response to compensate for the low energy.
  55. 55What is the mechanism in the development of a severe hypoglycaemic coma and what can reverse it?Hypoglycaemia results in the brain cells not receiving glucose and starving. Without enough energy to function, the response to this is unconsciousness (coma). This is reversible by raising the blood glucose with intravenous glucose or by injecting glucagon (which stops the insulin-glucose interaction).
  56. 56List four consequences of ketoacidosis that can lead to a coma.Hyperglycaemia, dehydration, shock, and exhaustion.
  57. 57What causes the exhaustion in a diabetic patient with ketoacidosis?The tachycardia and increased ventilation that the body produces in order to try to compensate for the raised concentrations of lactate and CO2 in the circulation.
  58. 58Why is there loss of fluid and dehydration in a diabetic patient with ketoacidosis?The hyperglycaemia draws fluid from the cells into the blood and it is then excreted in the urine.
  59. 59Describe the mechanism of a diabetic patient with ketoacidosis going into a coma.Dehydration and hyperglycaemia (and increased ion concentration as insulin is needed for some ions to enter cells) result in brain cells not having enough energy to function and causes unconsciousness/coma.
  60. 60Why are brain cells also starved of oxygen in a coma caused by diabetic ketoacidosis?Ketones have a low pKa and so their presence in the blood lowers its pH and reduces its capacity to carry oxygen for respiration. This makes the coma more severe and gives it a more rapid onset.
  61. 61Describe the mechanism of a nonketotic hyperosmolar coma, and explain the different between this and a coma resulting from ketoacidosis.Hyperglycaemia and the resulting dehydration result in a huge change in osmolarity and fluid loss. The brain cells (along with other bodily cells) are starved of energy, ions and water and so they react by switching off different processes and going into unconsciousness. However, ketone bodies are not present, unlike in a ketoacidotic coma, and so the blood pH is not lowered as drastically resulting in the oxygen carrying capacity being largely unaltered and the coma being less severe and the onset being slower.
  62. 62What is protein glycosylation, that occurs with hyperglycaemia?The process by which glucose binds to a wide variety of proteins by attaching to a free amino group.
  63. 63What sorts of proteins might be involved in protein glycosylation?Proteins which are not insulin-dependent, as well as extracellular structural proteins and circulating molecules, such as: haemoglobin, components of crystalline lens, fibrinogen, fibrin, collagens, myelin and antithrombin III.
  64. 64What is an initial property of glycosylated proteins that disappears with time?Initially, glycosylated proteins are labile and disassociate as soon as they form. However, with time, they undergo complex rearrangements to form stable advanced glycosylation products which are covalently bonded to amino acids.
  65. 65What happens to glycosylated proteins? What is the overall effect?The proteins to which glucose is bound to become inactivated (for example they have a lower oxygen affinity, or have difficulty clotting), and some cross-link with other proteins (for example glycosylated collagen cross-links with IgG). Not only is there loss of function such as difficulty clotting, but the clumping together of proteins/molecules could contribute to the formation of thrombi in vessels and the high CVD risk in diabetics.
  66. 66In diabetics, what is there a high rate of deposition of, which causes the membranes of vessels and organs to thicken?Basement membrane proteins.
  67. 67What are the effects of the glycosylation of basement membrane proteins?The basement membrane proteins, already deposited in vessel membranes, cross-link and may damage the vessel and predispose it to atherosclerosis.
  68. 68Why is healing impaired in glycosylation of blood proteins? What can this lead to?Clotting factors are inactivated by glycosylation and/or cross-linking with other proteins, and, along with impaired blood flow to the legs and feet, this can lead to the development of infections (because immunoglobulins are inactivated/trapped in complexes) and wounds which worsen over time and can lead to amputation.
  69. 69How might tissue necrosis occur as a result of protein glycosylation in diabetes? Where does this commonly occur?The glycosylated basement membrane proteins may damage the blood vessel membranes, as well as aggregating in the circulation, resulting in atherosclerosis and the formation of thrombi. Small clots may travel into small vessels in the peripheries and become stuck, impeding blood flow (and therefore nutrient/O2 delivery, CO2/waste removal) and leading to microvascular bleeds, hypoxia and necrosis. This commonly occurs in the kidney (diabetic nephropathy) and retinas (diabetic retinopathy).
  70. 70Roughly what proportion of both type 1 and type 2 diabetics develop renal failure?~30-40%
  71. 71What does the prevalence of diabetic nephropathy increase roughly in proportion with?The severity and duration of hyperglycaemia.
  72. 72What is the most common reason for kidney transplants in adults?Diabetic kidney disease!
  73. 73What is diabetic glomerulosclerosis and what are the two types of it?Diabetic glomerulosclerosis is a condition in which kidney function is impeded by the thickening of blood vessel membranes in the kidneys due to basement membrane protein deposition. This may be DIFFUSE, in which the membranes of afferent and efferent arterioles thicken and impede filtration, or NODULAR, in which spherical masses of basement membrane-like material accumulates in lobules.
  74. 74List three major manifestations of diabetic glomerulosclerosis.Proteinuria, haematuria and increased renal size.
  75. 75What is renal disease secondary to in diabetics?Microangiopathy (caused by glycosylation etc).
  76. 76How is diabetic glomerulosclerosis treated?The pathologic causes are usually irreversible, so treatment is by control of hyperglycaemia, dialysis, and kidney transplant.
  77. 77Name four eye conditions that commonly develop in diabetics. Which is the most devastating?Glaucoma, cataracts, corneal disease, and retinopathy. Of these, diabetic retinopathy is the most devastating.
  78. 78What is the prevalence of diabetic retinopathy dependent on?The duration and control of diabetes.
  79. 79What are the two types of diabetic retinopathy?Proliferative and non-proliferative.
  80. 80Describe the pathogenesis of non-proliferative diabetic retinopathy.Thickening of the small vessels occurs due to basement membrane protein deposition, and this is accompanied by progressively severe leakage of plasma constituents. Later in the pathogenesis, scattered arterioles and venules become obliterated, microaneurysms develop and tissue damage is caused by leakage of fluid. Haemorrhage, hypoxia and structural damage are caused by the bursting of microaneurysms and this leads to impaired vision or blindness.
  81. 81Describe the similarities and differences between non-proliferative and proliferative diabetic retinopathy.The basic pathogenesis is similar, in that basement membrane thickening results in the development of microaneurysms and these bursting can cause haemorrhage, hypoxia and structural damage. However, proliferative diabetic retinopathy is the more severe form of the disease and the ischaemic injury wrought by hypoxia results in angiogenesis and fibrous tissue formation in the retinas.
  82. 82What is the treatment for proliferative/non-proliferative diabetic retinopathy?There is no treatment and these are not reversible conditions, however hyperglycaemic control can maintain the condition of the disease rather than allowing it to worsen. Diabetic retinopathy generally leads to blindness.
  83. 83What is peripheral neuropathy?The loss of fine touch detection, pain detection and proprioception (knowing the position of the body and its parts in space) in the peripheries.
  84. 84What can cause peripheral neuropathy in diabetics?Prolonged hyperglycaemia, chronic kidney disease (e.g. glomerulosclerosis), vitamin deficiency (due to lack of insulin/reception), or poor blood flow to the legs.
  85. 85What effects does peripheral neuropathy tend to have in diabetics?Peripheral neuropathy can be the reason diabetics tend to ignore or don't notice irritation and/or minor trauma to the feet, joints and lower extremities, resulting in damage which can lead to infection and potentially amputation if the tissue damage is too severe to heal.
  86. 86What other neuropathies can occur in diabetics and what symptoms may be seen?Abnormalities of neurogenic regulation of cardiovascular and gastrointestinal function may be seen (autonomic nerve dysfunction). These may result in faintness, angina, or fatigue, or impaired digestion and vomiting.
  87. 87Give some reasons why immunity, in particular leukocyte function, is impaired in diabetes.Lack of energy, accumulation of leukocytes in viscous blood and accumulation of leukocytes in atherosclerotic vessels.
  88. 88Which effects of diabetes may increase the risk of infection?Retaining urine, neuropathy resulting in untreated trauma, or even necrosing of tissues.
  89. 89Which type of diabetes is hyperinsulinaemia common in and why?Type 2 diabetes, because insulin is still produced by the body but there is insensitivity of cells to insulin so it accumulates - hyperinsulinaemia.
  90. 90What can be the effects of hyperinsulinaemia?High concentrations of insulin the blood increase sodium retention in the kidneys which causes hypertension if untreated.
  91. 91What is the clinical presentation of a diabetic patient with hyperinsulinaemia?It may be asymptomatic, but can also include fatigue, headache and thirst.
  92. 92What is the treatment for hyperinsulinaemia?Diet control (reduction of simple sugar intake, increase in protein and fibre), physical exercise (which has been seen to improve insulin sensitivity), and monitoring of blood sugar to avoid hyperglycaemia.
  93. 93What is a blood glucose test?A test in which the patient fasts for 8 hours (usually overnight) and the blood is removed and separated and tested for the plasma glucose concentration.
  94. 94What is the normal fasting plasma glucose concentration?~90mg/dL or 5.6mM.
  95. 95What are the pre-diabetic and diabetic fasting plasma glucose concentrations?100-125mg/dL or 5.6-6.9mM, and >125mg/dL or >6/9mM respectively.
  96. 96What is a glucose tolerance test?Similar to a fasting glucose test, the patient must fast for at least 8 hours in order for their fasting glucose concentration to be determined, then they are given a solution of 75g of glucose dissolved in water. Plasma glucose concentration is measured (blood is drawn and separated) every 30 minutes for 2 hours.
  97. 97What is a normal glucose tolerance test result?After 2 hours, the blood glucose concentration returns to normal - 90mg/dL or <7.8mM.
  98. 98What are the pre-diabetic and diabetic results of a glucose tolerance test?In a pre-diabetic patient, the plasma glucose concentration plateaus at 140-199mg/dL, or 7.8-11mM. In a diabetic patient, the plasma glucose concentration remains elevated above 200mg/dL or >11mM.
  99. 99What does the slow response to a glucose tolerance test in pre-diabetic and diabetic patients indicate?That cells are not taking up and metabolising glucose normally.
  100. 100What do fasting plasma glucose and glucose tolerance tests indicate and not indicate about a person?They indicate that the body's response to increased glucose is not normal but neither distinguishes the cause (insulin synthesis, insulin release, or responsiveness of target tissues to insulin) and therefore the type of diabetes.
  101. 101How might the type of diabetes that a person has be distinguished?By clinical presentation, e.g. a thin, drawn appearance and presence of ketone bodies in type 1, or hyperinsulinaemia in type 2, may be enough to distinguish between the types. However, where a patient's symptoms are vague, overlapping or masked by comorbidities/complications, a C-peptide assay may be carried out. This may also be used as a definitive measure even when the clinical presentation is clear.
  102. 102What is C-peptide?C-peptide is a protein that links the α and β chains of insulin before they are cleaved and it is released.
  103. 103How will the results of a C-peptide assay differ between a type 1 diabetic and a type 2 diabetic?Type 1 diabetics will have a low plasma C-peptide concentration due to the low/lack of insulin production, whereas type 2 diabetics will have normal or increased (due to the initial compensation) plasma C-peptide concentration as they still produce insulin, but the body's sensitivity to it is decreased.
  104. 104What might dipstick tests show in a diabetic patient and/or a renal disease patient?Dipsticks are a quick, easy and cheap test for glucose, blood, protein, ketones and pH in urine. Glucose presence indicates hyperglycaemia in diabetes or impaired renal function, protein presence indicates renal disease (though this could be secondary to diabetes), and ketone presence indicates adipose metabolism in diabetes and will lower the pH of urine due to its acidic nature.
  105. 105How is type 1 diabetes treated?WITH INSULIN. Type 1 diabetics monitor their blood glucose concentrations and inject an appropriate amount of synthetic insulin to allow the glucose to be taken up and metabolised by cells. Monitoring of blood glucose concentration is important to avoid hyperglycaemia or hypoglycaemia and all the conditions and consequences related to these.
  106. 106How is type 2 diabetes treated?By maintaining a balanced diet low in simple sugars.
  107. 107What has minimising hyperglycaemia been seen to do in type 2 diabetics?Increase the sensitivity of cells to insulin.
  108. 108How does exercise minimise hyperglycaemia?Skeletal muscle does not require insulin for glucose uptake so glucose can be removed from the blood and used for respiration in exercise.
  109. 109How does weight loss minimise hyperglycaemia?Adipose tissue often promotes insulin resistance so loss of this results in proportionally decreased resistance. Further, weight loss generally involves a diet low in simple sugars which directly reduces hyperglycaemia.
  110. 110In which patients might bariatric surgery be recommended as a starting point for type 2 diabetes treatment? In which patients might this not be appropriate?Bariatric surgery may be best for obese patients for whom diet and exercise may cause undue cardiorespiratory distress, or for whom it is physically challenging. However, some of these patients may not be fit to undergo anaesthesia as a result of their weight and reduced cardiac capacity and so must lose weight by diet/light exercise so that surgery can be done.
  111. 111Who do GLP-1 and GIP do?These are incretins, they are released when glucose is present in the intestine and travel through the circulation to the pancreas where the stimulate insulin and amylin secretion from β cells.
  112. 112What do amylin and insulin do?Amylin slows the rate of digestion and the absorption of carbohydrates, while insulin acts on target tissues to promote uptake and metabolism of glucose.
  113. 113How might incretin mimetics, such as exendin-4, be used to treat type 2 diabetes?Exendin-4 is a drug which mimics GLP-1. Given that GLP-1 travels from the intestine when glucose is detected to the pancreas to stimulate the release of insulin and amylin, the drug can be used to increase insulin release as this is reduced after a period of uncontrolled diabetes in which insulin has little effect.
  114. 114Pramlintide mimics amylin. How might this be used in the treatment of type 2 diabetes?Amylin slows the rate of digestion and the absorption of carbohydrates in the small intestine so pramlintide can be used to replace the amylin that may not be secreted in high enough concentrations to maintain glycaemic control. After a period of uncontrolled diabetes, secretion of amylin and insulin is decreased when it is not effective so pramlintide can either counter this or can be used alongside the body's amylin secretion to further reduce simple sugar absorption and avoid hyperglycaemia.
  115. 115How might drugs which inhibit hepatic glucose release be used in the treatment of type 2 diabetes?Glycogenolysis in the liver occurs in diabetes when lack of insulin or lack of sensitivity to insulin disallows glucose in to cells and the body 'assumes' that there is no glucose available. However, in diabetes this merely worsens hyperglycaemia, so inhibitors of hepatic glucose release can help to prevent the consequences/complications of hyperglycaemia including protein glycosylation, reduced immunity, and thrombosis.
  116. 116How might drugs which make target tissues more responsive to insulin be used in the treatment of type 2 diabetes?This is the pathology of type 2 diabetes: insulin is produced and glucose is available but the target tissues are not sensitive to insulin and so it is not used to allow glucose into cells. Increasing the sensitivity allows insulin to function, allows cells the glucose they require for respiration and function, and maintains glycaemic control.
  117. 117What property of amylin, other than its ability to reduce digestion and carbohydrate absorption, makes it ideal for use in an obese/inactive type 2 diabetic before bariatric surgery?Amylin increases/promotes satiety and is involved in the appetite so drugs that mimic it or that increase its release can help obese/inactive patients to lose weight for undergoing anaesthesia without putting them under undue cardiorespiratory distress.
  118. 118Why might insulin be used in the treatment of type 2 diabetes?To minimise hyperglycaemia that has resulted from low insulin production (which develops after prolonged insulin insensitivity) or from lack of conformity to other treatments.
  119. 119List some drug classes that stimulate insulin secretion.Sulphonylureas, meglitinides, and DPP4 inhibitors. The latter also decreases gastric emptying.
  120. 120List some drug classes that reduce plasma glucose concentration.Biguanides (e.g. metformin) decrease hepatic gluconeogenesis, amylin analogs (e.g. pramlinitide) reduce glucose absorption, and incretin (GLP-1) analogs (e.g. exendin-4) stimulate insulin release from β cells.
  121. 121Along with amylin analogs such as pramlinitide, which other drug class reduces intestinal glucose uptake?Alpha-glucosidase inhibitors.
  122. 122What do PPAR activators (or 'glitazones') do in diabetes treatment?Increase gene transcription for proteins that promote glucose utilisation and fatty acid metabolism.

Information

Description
(Biology of Disease) Flashcards on Diabetes mellitus, created by sophietevans on 12/08/2013.
Created by
sophietevans
Views
259
Tags
biology of disease
Rating

More on Diabetes Mellitus

Feedback

What is it about?

What should we add next?